Aurobindo Pharma reported INR327.09B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Cipla INR 241.47B 7.71B Mar/2026
Divis Laboratories Ltd INR 110.96B 12.53B Mar/2026
Dr.Reddys Laboratories INR 301.79B 4.24B Mar/2026
Hindustan Unilever INR 190.21B 10.76B Mar/2026
Sun Pharmaceuticals INR 638.6B 37.24B Mar/2026
UPL INR 422.95B 9.97B Mar/2026